Sodium‐glucose co‐transporter‐2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Liu, Jiali; Li, Ling; Li, Sheyu; Wang, Yuning; Qin, Xuan; Deng, Ke; Liu, Yanmei; Zou, Kang; Sun, Xin

doi:10.1111/dom.14075

Public

Sodium‐glucose co‐transporter‐2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: A systematic review and meta‐analysis of randomized controlled trials

Published in Diabetes Obesity and Metabolism • May 4, 2020

Authors:

Jiali Liu

Ling Li

Sheyu Li

Abstract

AIM: To assess the effects of sodium-glucoseco-transporter-2 (SGLT2) inhibitors on diabetic ketoacidosis (DKA) in patients with type 2 diabetes. MATERIALS AND METHODS: We searched PubMed, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL) and ClinicalTrials.gov from inception to 13 Jun...

Subject

Medicine

Diabetic ketoacidosis

Randomized controlled trial

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!